The DOI matches its Crossref record; 306 of the 306 references it cites were found in a registry or an index.
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Open accessAbstract
Alzheimer's disease is a neurological disorder that results in cognitive and behavioral impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs, often fail due to their poor solubility, lower bioavailability, and ineffective ability to cross the blood-brain barrier. Nanotechnological treatment methods, which involve the design, characterization, production, and application of nanoscale drug delivery systems, have been employed to optimize therapeutics. These nanotechnologies include polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, microemulsion, nanoemulsion, and liquid crystals. Each of these are promising tools for the delivery of therapeutic devices to the brain via various routes of administration, particularly the intranasal route. The objective of this study is to present a systematic review of nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–306 of 306
Pharmacokinetic study of memantine in healthy and renally impaired subjects
Periclou, A. P., Ventura, D., RAO, N., & Abramowitz, W. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.10.005 · Cited by 108
The blood-brain barrier and nasal drug delivery to the central nervous system
Miyake, M. M., & Bleier, B. S. (2015) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2015.29.4149 · Cited by 106
Comparison of Extruded and Sonicated Vesicles for Planar Bilayer Self-Assembly
Cho, N., Hwang, L. Y., Solandt, J., & Frank, C. W. (2013) · Materials · doi:10.3390/ma6083294 · Cited by 104
Teng, E., Ringman, J. M., Ross, L., Mulnard, R. A., Dick, M. B., Bartzokis, G., Davies, H. D., Galasko, D. R., Hewett, L., Mungas, D., et al. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318165dbae · Cited by 102
The Treatment of Alzheimer Disease
Winslow, B. T., Onysko, M. K., Stob, C. M., & Hazlewood, K. A. (2008) · Springer eBooks · doi:10.1007/978-3-540-87523-9_6 · Cited by 101
Nanobiotechnology-based drug delivery to the central nervous system.
Jain, K. K. (2007) · Neurodegenerative Diseases · doi:10.1159/000101884 · Cited by 100 · cited 10×
“Finally, a combination of the effects described above can be used (Figure 3).(158,160,163) NPs can also be administered nasally to promote absorption(169) and delivery to the brain.”
InfluentialButterfield, D. A., Yatin, S. M., Varadarajan, S., & Koppal, T. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09050-3 · Cited by 99
Intranasal therapeutic strategies for management of Alzheimer’s disease
Sood, S., Jain, K., & Gowthamarajan, K. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2013.876644 · Cited by 99
Targeting Nanoparticles Across The Blood–Brain Barrier with Monoclonal Antibodies
Loureiro, J. A., Gomes, B., Coelho, M. A. N., Pereira, M. D. C., & Rocha, S. (2014) · Nanomedicine · doi:10.2217/nnm.14.27 · Cited by 99
Advances in the Treatment of Neurodegenerative Disorders Employing Nanoparticles
Spuch, C., Ortolano, S., & Navarro, C. (2012) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221112799219125 · Cited by 99
Ismail, M. F., ElMeshad, A. N., & Salem, N. A. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s39232 · Cited by 97
Re, F., Salvati, Sesana, Cambianica, Sancini, G., Masserini, & Gregori (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s42783 · Cited by 93
Nanoparticles and nanocapsules--new dosage forms in the nanometer size range.
Kreuter, J. (1978) · PubMed · Cited by 93
Guri, A., Gülseren, İ., & Corredig, M. (2013) · Food & Function · doi:10.1039/c3fo60180c · Cited by 92
Targeting Tau Protein in Alzheimerʼs Disease
Gong, C., Grundke, I., & Iqbal, K. (2010) · Drugs & Aging · doi:10.2165/11536110-000000000-00000 · Cited by 90
Carvalho, F. C., de Campos, M. L., Peccinini, R. G., & Gremião, M. P. D. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.11.021 · Cited by 89
Development of a nanoparticle-based influenza vaccine using the PRINT® technology
Galloway, A. L., Murphy, A., DeSimone, J. M., Di, J., Herrmann, J. P., Hunter, M. E., Kindig, J. P., Malinoski, F. J., Rumley, M. A., Stoltz, D. M., et al. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.001 · Cited by 87
Memantine: a comprehensive review of safety and efficacy
Kavirajan, H. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802528420 · Cited by 86
Generative FDG-PET and MRI Model of Aging and Disease Progression in Alzheimer's Disease
Dukart, J., Kherif, F., Mueller, K., Adaszewski, S., Schroeter, M. L., Frackowiak, R. S. J., Draganski, B., & Initiative, A. D. N. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002987 · Cited by 86
Gattaz, W. F., Förstl, H., Braus, D. F., Maras, A., Cairns, N. J., & Levy, R. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189113 · Cited by 84
Dong, Y., Ng, W. K., Shen, S., Kim, S., & Tan, R. B. H. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.01.018 · Cited by 83
Pupo, E., Padrón, A., Santana, E., Sotolongo, J., Quintana, D., Dueñas, S., Duarte, C. A., de la Rosa, M. C., & Hardy, E. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.001 · Cited by 82
New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations
Ağardan, N. B. M., Değim, Z., Yılmaz, Ş., Eşsiz, D., & Nacar, A. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.541262 · Cited by 80
Lister‐James, J., Pontecorvo, M. J., Clark, C. M., Joshi, A. D., Mintun, M. A., Zhang, W., Lim, N. C., Zhuang, Z., Golding, G., Choi, S., et al. (2011) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2011.03.001 · Cited by 79
Mourão, S. C., da Costa, P. I., Salgado, H. R. N., et al. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.009 · Cited by 78
Optimization of Copaiba oil-based nanoemulsions obtained by different preparation methods
Dias, D. D. O., Colombo, M., Kelmann, R. G., Kaiser, S., Lucca, L. G., Teixeira, H. F., Limberger, R. P., da Veiga, V. F., & Koester, L. (2014) · Industrial Crops and Products · doi:10.1016/j.indcrop.2014.05.007 · Cited by 77
Mono and Dually Decorated Nanoliposomes for Brain Targeting, In Vitro and In Vivo Studies
Markoutsa, E., Παπαδιά, Κ., Giannou, A. D., Σπέλλα, Μ., Cagnotto, A., Salmona, M., Stathopoulos, G. T., & Antimisiaris, S. G. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1249-3 · Cited by 76
Praziquantel-loaded PLGA nanoparticles: preparation and characterization
Mainardes, R. M., & Evangelista, R. C. (2005) · Journal of Microencapsulation · doi:10.1080/02652040400026285 · Cited by 75
Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A
Patel, P. A., Patil, S. C., Kalaria, D. R., Kalia, Y. N., & Patravale, V. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.014 · Cited by 74
Bondì, M. L., Montana, G., Craparo, E. F., Picone, P., Capuano, G., Carlo, M. D., & Giammona, G. (2009) · Current Nanoscience · doi:10.2174/157341309787314656 · Cited by 70
Carvalho, F. C., Barbi, M. D. S., Sarmento, V. H. V., Chiavacci, L. A., Netto, F. M., & Gremião, M. P. D. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.04.0004 · Cited by 70
SLN approach for nose-to-brain delivery of alprazolam
Singh, A. P., Saraf, S. K., & Saraf, S. A. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0110-2 · Cited by 69
Enhanced Apoptotic Effect of Curcumin Loaded Solid Lipid Nanoparticles
Kakkar, V., Bhushan, S., Santosh, K. G., & Pal, K. I. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300209k · Cited by 65
Ultrasound-mediated drug delivery using liposomes modified with a thermosensitive polymer
Ninomiya, K., Kawabata, S., Tashita, H., & Shimizu, N. (2013) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2013.07.014 · Cited by 64
Nanotechnology for CNS delivery of bio-therapeutic agents
Shah, L. K., Yadav, S. K., & Amiji, M. M. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0133-3 · Cited by 64
Formulation and Evaluation of Niosomal Nasal Drug Delivery System of Folic Acid for Brain Targeting
Ravouru, N., Kondreddy, P., Korakanchi, D., & Haritha, M. M. (2013) · Current Drug Discovery Technologies · doi:10.2174/15701638113109990031 · Cited by 64
Nanostructure-based drug delivery systems for brain targeting
Haque, S., Md, S., Alam, M. I., Sahni, J. K., Ali, J., & Baboota, S. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.608191 · Cited by 62
Platelet phospholipase A 2 activity in Alzheimer?s disease and mild cognitive impairment
Gattaz, W. F., Forlenza, O. V., Talib, L. L., Barbosa, N. R., & Bottino, C. M. C. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0142-y · Cited by 62
Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier
Rosa, G. D., Salzano, G., Caraglia, M., & Abbruzzese, A. (2011) · Current Drug Metabolism · doi:10.2174/138920012798356943 · Cited by 62
Nanoemulsions for delivery of flavonoids: formulation andin vitrorelease of rutin as model drug
Macedo, A. S., Quelhas, S., Silva, A. M., & Souto, E. B. (2013) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2013.823989 · Cited by 61
Crystallographic investigation of cetylpalmitate solid lipid nanoparticles
Lukowski, G., Kasbohm, J., Pflegel, P., et al. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00421-4 · Cited by 61
Hadian, Z., Sahari, M. A., Moghimi, H. R., & Barzegar, M. (2014) · PubMed Central · Cited by 59
Ye, P., Zhang, W., Tan, Y., Lu, Y., Lu, M., Gai, Y., Ma, X., & Xiang, G. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s60178 · Cited by 59
Brambilla, D., Verpillot, R., Taverna, M., Kimpe, L. D., Droumaguet, B. L., Nicolas, J., Canovi, M., Gobbi, M., Mantegazza, F., Salmona, M., et al. (2010) · Analytical Chemistry · doi:10.1021/ac102045x · Cited by 59
Härtig, W., Paulke, B., Varga, C., Seeger, J., Harkany, T., & Kacza, J. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01399-x · Cited by 58
Chung, S. K., Shin, G. H., Jung, M. K., Hwang, I. C., & Park, H. J. (2014) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2014.03.095 · Cited by 57
Chaiyana, W., Rades, T., & Okonogi, S. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.005 · Cited by 57
Kornhuber, J., Kennepohl, E. M., Bleich, S., et al. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746070-00005 · Cited by 56
Intranasal Delivery—Modification of Drug Metabolism and Brain Disposition
Wong, Y. C., & Zuo, Z. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0127-5 · Cited by 55
Dementia: Diagnosis and Evaluation
Fleming, K. C., Adams, A. C., & Petersen, R. C. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.11.1093 · Cited by 55
Protective Effects of Curcumin on Amyloid-β-Induced Neuronal Oxidative Damage
Huang, H., Chang, P., Dai, X., & Jiang, Z.-F. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0754-9 · Cited by 54
The Safety and Lack of Efficacy of Vinpocetine in Alzheimer's Disease
Thal, L. J., Salmon, D. P., Lasker, B. R., et al. (1989) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1989.tb05682.x · Cited by 54
Ghanbarzadeh, S., Valizadeh, H., & Zakeri‐Milani, P. (2013) · PubMed · doi:10.5681/bi.2013.016 · Cited by 54
Supramolecular devices to improve the treatment of brain diseases
Paolino, D., Cosco, D., Molinaro, R., Celia, C., & Fresta, M. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.006 · Cited by 53
Sancini, G. (2013) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000171 · Cited by 53
Ligand-functionalized nanoliposomes for targeted delivery of galantamine
Mufamadi, M. S., Choonara, Y. E., Kumar, P., Modi, G., Naidoo, D., van Vuuren, S., Ndesendo, V. M. K., Toit, L. C. D., Iyuke, S. E., & Pillay, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.037 · Cited by 51
Neuropsychology of Vitamin B₁₂ Deficiency in Elderly Dementia Patients and Control Subjects
Osimani, A., Berger, A., Friedman, J. A., Porat‐Katz, B., & Abarbanel, J. M. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704272308 · Cited by 51
Treatment of Alzheimer Disease
Geldmacher, D. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001503 · Cited by 51
Cholinergic Markers in Alzheimer Disease
Bartus, R. T., & Emerich, D. F. (1999) · JAMA · doi:10.1001/jama.282.23.2208 · Cited by 49
Bruschi, M. L., de Freitas, O., Lara, E. H. G. E., Panzeri, H., Gremião, M. P. D., & Jones, D. S. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040701655911 · Cited by 49
Loading of praziquantel in the crystal lattice of solid lipid nanoparticles
de Souza, A. L. R., Andreani, T., Nunes, F. M., Cassimiro, D. L., de Almeida, A. E., Ribeiro, C. A., Sarmento, V. H. V., Gremião, M. P. D., Silva, A. M., & Souto, E. B. (2011) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-011-1871-4 · Cited by 49
Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook
Tayebati, S. K., Nwankwo, I. E., & Amenta, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804143662 · Cited by 49
Computed Tomography in the Elderly: Changes over Time in a Normal Population
Bird, J. M., Levy, R., & Jacoby, R. J. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.148.1.80 · Cited by 47
Pharmacokinetics and metabolism of idebenone in healthy male subjects
Bodmer, M., Vankan, P., Dreier, M., Kutz, K., & Drewe, J. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0596-1 · Cited by 47
Ćurić, A., Reul, R., Möschwitzer, J. P., & Fricker, G. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.029 · Cited by 46
Kozlovskaya, L., & Stepensky, D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.028 · Cited by 46
Sinha, M. S., Bhowmick, P., Banerjee, A., & Chakrabarti, S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.036 · Cited by 45
Antioxidant idebenone-loaded nanoparticles based on chitosan and N-carboxymethylchitosan
Krueger, C. D. M. A., Couto, A. G., Netz, D. J. A., de Freitas, R. A., & Bresolin, T. M. B. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.06.006 · Cited by 45
dos Santos, F. K., Garnero, C., de Oliveira, R. N., de Souza, A. L. R., Chorilli, M., Allegretti, S. M., Longhi, M. R., Chaud, M. V., & Gremião, M. P. D. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2015.9186 · Cited by 45
Self-citationTargeted Drug Delivery Across the Blood Brain Barrier in Alzheimer’s Disease
Rocha, S. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990613 · Cited by 45
Development and in vitro evaluation of surfactant systems for controlled release of zidovudine
Carvalho, F. C., Sarmento, V. H. V., Chiavacci, L. A., Barbi, M. D. S., & Gremião, M. P. D. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22005 · Cited by 44
Towards designer nanoemulsions for precision delivery of therapeutics
Sainsbury, F., Zeng, B., & Middelberg, A. P. J. (2014) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2013.12.007 · Cited by 42
Metal Chelator Decreases Alzheimer β-Amyloid Plaques
Gouras, G. K., & Beal, M. F. (2001) · Neuron · doi:10.1016/s0896-6273(01)00330-0 · Cited by 42
Bentley, P., Driver, J., & Dolan, R. J. (2009) · Brain · doi:10.1093/brain/awp176 · Cited by 41
Preparação de nanopartículas poliméricas a partir da polimerização de monômeros: parte I
Souto, E. B., Severino, P. B., & Santana, M. H. A. (2012) · Polímeros · doi:10.1590/s0104-14282012005000006 · Cited by 37
Carvalho, F. C., Chorilli, M., & Gremião, M. P. D. (2014) · Polímeros · doi:10.4322/polimeros.2014.043 · Cited by 36
Self-citationAmyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study
Verma, A. (2008) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(08)79016-1 · Cited by 35
García‐Jimeno, S., Escribano, E., Queralt, J., & Estelrich, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.11.044 · Cited by 34
Enhanced Delivery of Lopinavir to the Cns Using Compritol®-Based Solid Lipid Nanoparticles
Raynold, A. A. M., Paul, W., Chacko, A. J., & Sharma, C. P. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.96 · Cited by 34
Kuo, Y., & Hong, T.-Y. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.02.008 · Cited by 32
Gattaz, W. F., Talib, L. L., Schaeffer, E. L., Diniz, B. S., & Forlenza, O. V. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1088-8 · Cited by 32
Shi, J., Cong, W., Wang, Y., Liu, Q., & Luo, G. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.625031 · Cited by 31
Controlled Release and Nanotechnology
Betancourt, T., Doiron, A. L., Homan, K. A., & Brannon‐Peppas, L. (2008) · Springer eBooks · doi:10.1007/978-0-387-77668-2_10 · Cited by 30
Designing the future of nanomedicine: current barriers to targeted brain therapeutics
Herda, L. M., Polo, E., Kelly, P. M., Rocks, L., Hudecz, D., & Dawson, K. A. (2014) · European Journal of Nanomedicine · doi:10.1515/ejnm-2014-0022 · Cited by 30
Improved adhesion to mucosal cells of water-soluble chitosan tetraalkylammonium salts
Cardile, V., Frasca, G., Rizza, L., Bonina, F. P., Puglia, C., Barge, A., Chiambretti, N., & Cravotto, G. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.017 · Cited by 27
Coenzyme Q10 nanoparticles prepared by a supercritical fluid-based method
Hu, X., Guo, Y., Wang, L., Hua, D., Hong, Y., & Li, J. (2011) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2011.01.007 · Cited by 27
Sood, S., Jain, K., & Gowthamarajan, K. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.609 · Cited by 25
Redispersible lipid nanoparticles of Spironolactone obtained by three drying methods
Bourezg, Z., Bourgeois, S., Pressenda, S., Shehada, T., & Fessi, H. (2012) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2012.03.027 · Cited by 23
Pharmacoscintigraphic Evaluation of Polysorbate80-Coated Chitosan Nanoparticles for Brain Targeting
Soni, S., Babbar, A. K., Sharma, R. K., et al. (2005) · American Journal of Drug Delivery · doi:10.2165/00137696-200503030-00004 · Cited by 20
Advances in Nanotechnology-Based Drug Delivery Platforms and Novel Drug Delivery Systems
Suri, K. A., Wolfram, J., Shen, H., & Mauro Ferrari, B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-416603-5.00003-1 · Cited by 19
Değim, Z., Mutlu, N. B., Yılmaz, Ş., Eşsiz, D., & Nacar, A. (2010) · Die Pharmazie · doi:10.31083/ph.2010.9179 · Cited by 19
Various Pharmaceutical Disperse Systems
Manoharan, C., Basarkar, A., & Singh, J. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1087-5_1 · Cited by 18
Amyloid, hypometabolism, and cognition in Alzheimer disease - An [11C]PIB and [18F]FDG PET study
Edison, P., Archer, H. A., Hinz, R., Hammers, A., Pavese, N., Tai, Y., Hotton, G. R., Cutler, D., Fox, N. C., Kennedy, A. M., et al. (2007) · UCL Discovery (University College London) · Cited by 17
Demência por neurossífilis: evolução clínica e neuropsicológica de um paciente
Vargas, A. P., Carod-Artal, F. J., NEGRO, M. C. D., & Rodrigues, M. P. C. (2000) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2000000300029 · Cited by 16
Brambilla, D., Verpillot, R., Kimpe, L. D., Taverna, M., Droumaguet, B. L., Nicolas, J., Canovi, M., Gobbi, M., Salmona, M., Nicolas, V., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.084 · Cited by 15
Agitation during lipoplex formation harmonizes the interaction of siRNA to cationic liposomes
Barichello, J. M., Kizuki, S., Tagami, T., Soares, L. A. L., Ishida, T., Kikuchi, H., & Kiwada, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.006 · Cited by 14
Key Aspects in Nanotechnology and Drug Delivery
Arias, J. L. (2014) · CRC Press eBooks · doi:10.1201/b17271-2 · Cited by 11
Frozza, R. L., Salbego, C. G., Bernardi, A., Hoppe, J. B., Meneghetti, A., Battastini, A. M. O., Guterres, S. S., & Pohlmann, A. R. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.286 · Cited by 10
Dermal delivery of drugs using different vesicular carriers: A comparative review
Arora, S., Lamba, H., & Tiwari, R. K. (2012) · Asian Journal of Pharmaceutics · doi:10.4103/0973-8398.107558 · Cited by 9
Patents on Brain Permeable Nanoparticles
Gulati, M., Chopra, D., Singh, S. K., Saluja, V., Pathak, P., & Bansal, P. (2014) · Recent Patents on CNS Drug Discovery · doi:10.2174/1574889808666131128105141 · Cited by 7
Dermal delivery of drugs using different vesicular carriers: A comparative review
Arora, S., Lamba, H., & Tiwari, R. K. (2012) · Asian Journal of Pharmaceutics · doi:10.22377/ajp.v6i4.40 · Cited by 6
P4‐198: Liposomal delivery of a beta sheet blocker peptide for the treatment of Alzheimer's disease
Kumaraswamy, P., Sethuraman, S., & Krishnan, U. M. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.1902 · Cited by 3
Rasmussen, K. L., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.07.1262 · Cited by 3
Evaluation of brain-targeting of β-asarone microemulsion by intranasal administration
Long-ka, Z. (2014) · Zhongcaoyao · Cited by 2
Sood, S., Jain, K., & Gowthamarajan, K. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.610 · Cited by 1
Cited by
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Nanoparticles in Drug Delivery: From History to Therapeutic Applications
Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468
Applications of nanotechnology in drug delivery to the central nervous system
Saeedi, M., Eslamifar, M., Khezri, K., & Dizaj, S. M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.133 · Cited by 342
Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306
Metadata
- Authors
- Fonseca-Santos, B., Chorilli, M., & Palmira Daflon Gremião, M.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2015-08
- Volume
- 10
- Pages
- 4981
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W1834838125
- Cited by
- 308
- References
- 306
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.